Tau PET Scan
Showing 1 - 25 of 9,994
Cognitive Impairment Trial in Jacksonville (Tau PET scan)
Enrolling by invitation
- Cognitive Impairment
- Tau PET scan
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 31, 2022
Health Disparities Tau Positron Emission Tomography Scan Study
Enrolling by invitation
- Alzheimer Disease
- PI-2620 tracer for Tau PET scan
-
Fort Worth, TexasUniversity of North Texas Health Science Center
Oct 12, 2021
Tau Networks in Psychotic Alzheimer's Disease
Recruiting
- Alzheimer Disease
- +2 more
- [18F]-PI2620 PET scan
-
Manhasset, New YorkThe Feinstein Institutes for Medical Research
Apr 26, 2023
Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan Trial (18F-PMPBB3 (APN-1607) PET imaging)
Recruiting
- Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan
- 18F-PMPBB3 (APN-1607) PET imaging
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 24, 2022
Alzheimer, Cognitive Impairment, Cognitive Decline Trial in Irvine (radiation, drug, behavioral, other)
Recruiting
- Alzheimer Disease
- +2 more
- Amyloid PET scan
- +3 more
-
Irvine, CaliforniaUniversity of California, Irvine
Nov 2, 2020
Cohort Study of Blood Biomarkers for TES
Recruiting
- Chronic Traumatic Encephalopathy
- +2 more
- Blood tests, Cognitive function tests, head MRI (plain scan and DTI sequence) examination and head PET (FDG-PET, Tau-PET and Amyloid-PET) examination
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Dec 1, 2021
Opioid-Related Disorders Trial in Philadelphia (18F-PI-2620 PET/CT)
Not yet recruiting
- Opioid-Related Disorders
- 18F-PI-2620 PET/CT
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 13, 2023
Tau PET/CT Imaging in Mismatch Prospective Cohort Study
Recruiting
- Alzheimer's Disease
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 6, 2023
Mild Cognitive Impairment Trial in Philadelphia (2-(2-([18F]fluoro)pyridin-4-yl)-9H-pyrrolo[2,3-b:4,5-c']dipyridine)
Recruiting
- Mild Cognitive Impairment
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, School of Medicine
Dec 9, 2022
Primary Progressive Aphasia Trial in Rochester (F-18 AV 1451)
Enrolling by invitation
- Primary Progressive Aphasia
- F-18 AV 1451
-
Rochester, MinnesotaMayo Clinic
Apr 7, 2022
Frontotemporal Lobar Degeneration, Alzheimer, Cognitively Normal Trial in Philadelphia ([18F]PI-2620)
Not yet recruiting
- Frontotemporal Lobar Degeneration
- +2 more
-
Philadelphia, PennsylvaniaPerelman Center for Advance Medicine
Jul 13, 2022
Cognitive Decline, Alzheimer Trial in Philadelphia ((18F)Flortaucipir)
Recruiting
- Cognitive Decline
- Alzheimer Disease
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania - Penn Memory Center
Dec 9, 2022
Chronic Traumatic Encephalopathy, Traumatic Encephalopathy, Head Injury Trauma Trial in Macquarie Park ([18F] PI-2620 Tau
Recruiting
- Chronic Traumatic Encephalopathy
- +4 more
- [18F] PI-2620 Tau Ligand
-
Macquarie Park, New South Wales, AustraliaMacquarie Medical Imaging
Aug 4, 2022
Neurodegenerative Disease Trial in Philadelphia ([18F]T807)
Recruiting
- Neurodegenerative Disease
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Mar 24, 2022
Tauopathies Trial in Philadelphia (Amyloid PET scan, Brain MRI Scan, Neurologic exam)
Recruiting
- Tauopathies
- Amyloid PET scan
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 14, 2023
Prostate Cancer Diagnosis Trial in Los Angeles (diagnostic test, other, drug)
Not yet recruiting
- Prostate Cancer Diagnosis
- PSMA PET scan
- +2 more
-
Los Angeles, CaliforniaVA Greater Los Angeles Healthcare System
Apr 20, 2023
F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's
Recruiting
- Alzheimer Disease
- F 18 T807
-
Saint Louis, MissouriWashington University School of Medicine
Sep 23, 2022
Cancer Trial in Manchester (Y90-PET-CT scan)
Recruiting
- Cancer
- Y90-PET-CT scan
-
Manchester, United KingdomThe Christie NHS - Nuclear Medicine Department
Nov 7, 2023
Alzheimer Trial in Canada, United States (18F-Flortaucipir radiopharmaceutical, 18F-MK-6240 radiopharmaceutical, Amyloid-ß
Recruiting
- Alzheimer Disease
- 18F-Flortaucipir radiopharmaceutical
- +2 more
-
Berkeley, California
- +7 more
Jan 23, 2023
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
Recruiting
- Mild Cognitive Impairment
- Aging
-
New York, New YorkColumbia University Medical Center
Feb 10, 2022
Alzheimer, Benson's Disease Trial in Tours ([18F]T807 PET)
Completed
- Alzheimer Disease
- Benson's Disease
- [18F]T807 PET
-
Tours, FranceUniversity Hospital of Tours
Sep 8, 2022
18F-TFB PET/CT Scan in Differentiated Thyroid Cancer
Recruiting
- Differentiated Thyroid Gland Carcinoma
- +2 more
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Malignant Glioma, Recurrent Brain Tumor Trial in Rochester (procedure, drug, other)
Active, not recruiting
- Malignant Glioma
- Recurrent Brain Neoplasm
- Biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2023